Kevin and Janice press their luck when they first come across The World for a Dollar deal.
http://www.lastminutetravel.com/world-for-a-dollar.aspx
THE WORLD FOR A DOLLAR
15 Minutes a day
15,000 Hotels
$1 a Night
Hotel prices have experienced pronounced volatility as a result of political turmoil and natural disasters in the first half of 2011, according to the latest Hotels.com® Hotel Price Index™ (HPI®).
The average price of a room around the world rose by just 3% in the first six months of the year but this masked some steep rises and falls in regions affected by the historic events.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/hotels/50554/
For the first time in five years, travellers paid more on average for their hotel rooms during the first six months of 2012 in all parts of the world, according to the latest Hotels.com® Hotel Price Index TM (HPI®). The global 4% rise, compared to the same period the year before, demonstrated that the economic recovery in the hotel industry was well-established.
The Index stood at 108 for this period meaning that, despite the latest increase, hotel prices in general were still considerably lower than in the first half of 2007 when the HPI was at its peak of 119.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56589-global-hotel-prices-rise-in-all-regions
Temp Agencies in Louisiana. Baystone Contractors have years of experience supplying 1st class, quality Blue Collar workers from offices in Louisiana.
New Orleans, Houma and Lafayette.
www.baystonecontractors.com/blog/our-services
We supply welders, fitters, pipe fitters, ship fitters, sand blasters, mechanics, machinists and more at very competitive rates.
Call Today for More Information
Kyle: 337.316.5993
Hi-Tech CADD Services provides 3d interior rendering, architectural 3d rendering, 3d animation, 3d interior design at cost effective rates in India. E-mail us your query at info@hitechcaddservices.com
Colocating in Los Angeles can put your company ahead of the curve with superior data transfer rates. Colocation America has over a decade of experience in providing trusted, reliable Los Angeles colocation services. http://www.ColocationAmerica.com
C. R. Bard, Inc. today announced the publication of RESILIENT trial results by Circulation: Cardiovascular Interventions showing the Bard LifeStent® Vascular Stent improved patency and reduced revascularization rates in patients with moderate-length lesions in the superficial femoral artery (SFA) and proximal popliteal artery compared to patients treated with percutaneous transluminal angioplasty (PTA).
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/bard/44623/
The Johns Hopkins University Applied Physics Laboratory (APL), with help from The Boeing Company [NYSE: BA] and Iridium Communications Inc. [Nasdaq: IRDM], has successfully implemented a new space-based system to monitor Earth’s space environment. Known as the Active Magnetosphere and Planetary Electrodynamics Response Experiment (AMPERE), the system provides real-time magnetic field measurements using commercial satellites as part of a new observation network to forecast weather in space. This is the first step in developing a system that enables 24-hour tracking of Earth's response to supersonic blasts of plasma ejected from the sun at collection rates fast enough to one day enable forecasters to predict space weather effects.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/iridium/45153/
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced The New England Journal of Medicine has published results from the North American Phase 3 trial evaluating the safety and efficacy of the Company’s novel antibiotic fidaxomicin as a treatment for patients with Clostridium difficile infection (CDI). The Phase 3 trial showed that fidaxomicin significantly reduced recurrence rates and increased global cure rates when compared to vancomycin, the only treatment approved by the U.S. Food and Drug Administration for CDI. The article titled,
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/
http://www.colocationamerica.com/data_center - Colocation America has 22 premier data centers located in San Francisco, Los Angeles, New York, New Jersey, and Chicago. Our data centers feature the best server hosting environment, providing our industry leading colocation and dedicated server hosting services. Our data centers are located in optimal areas, maximizing data transfer rates. Our blend of 16 tier-one providers and private peering arrangements worldwide provides over 55% peering, resulting in the ultimate premium bandwidth.
